Literature DB >> 18265303

Generation of HIV-1-based lentiviral vector particles.

Ali Ramezani1, Robert G Hawley.   

Abstract

This unit presents protocols outlining the methodology and techniques involved in the construction and application of HIV-1-based lentiviral vector systems. Also described are procedures that can be used to concentrate and purify high-titer recombinant lentiviral vector preparations, as well as protocols for transduction of adherent and suspension cells.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 18265303     DOI： 10.1002/0471142727.mb1622s60

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN： 1934-3647


  10 in total

1.  Optogenetic approaches to characterize the long-range synaptic pathways from the hypothalamus to brain stem autonomic nuclei.

Authors:  Ramón A Piñol; Ryan Bateman; David Mendelowitz
Journal:  J Neurosci Methods       Date:  2012-08-07       Impact factor: 2.390

2.  Lentiviral-mediated RNAi knockdown yields a novel mouse model for studying Cyp2b function.

Authors:  Basma Damiri; Eric Holle; Xianzhong Yu; William S Baldwin
Journal:  Toxicol Sci       Date:  2011-11-14       Impact factor: 4.849

3.  Lentiviral fluorescent protein expression vectors for biotinylation proteomics.

Authors:  Irene Riz; Teresa S Hawley; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2011

4.  Strategies to insulate lentiviral vector-expressed transgenes.

Authors:  Ali Ramezani; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2010

5.  Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs).

Authors:  Ja Hye Myung; Cari A Launiere; David T Eddington; Seungpyo Hong
Journal:  Langmuir       Date:  2010-06-01       Impact factor: 3.882

6.  Phosphorylation of HSP27 by protein kinase D is essential for mediating neuroprotection against ischemic neuronal injury.

Authors:  R Anne Stetler; Yanqin Gao; Lili Zhang; Zhongfang Weng; Feng Zhang; Xiaoming Hu; Suping Wang; Peter Vosler; Guodong Cao; Dandan Sun; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

7.  Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo.

Authors:  Tong Xu; Yucheng Xu; Chun-Peng Liao; Roy Lau; Amir Goldkorn
Journal:  Mol Cancer Ther       Date:  2010-02-02       Impact factor: 6.261

8.  MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency.

Authors:  Marco Miceli; Gianluigi Franci; Carmela Dell'Aversana; Francesca Ricciardiello; Francesca Petraglia; Annamaria Carissimo; Lucia Perone; Giuseppe Maria Maruotti; Marco Savarese; Pasquale Martinelli; Massimo Cancemi; Lucia Altucci
Journal:  Stem Cells Dev       Date:  2013-05-24       Impact factor: 3.272

9.  Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.

Authors:  Yuh-Ying Yeh; Rong Chen; Joshua Hessler; Emilia Mahoney; Amy M Lehman; Nyla A Heerema; Michael R Grever; William Plunkett; John C Byrd; Amy J Johnson
Journal:  Oncotarget       Date:  2015-02-20

10.  Acetylation of BMAL1 by TIP60 controls BRD4-P-TEFb recruitment to circadian promoters.

Authors:  Nikolai Petkau; Harun Budak; Xunlei Zhou; Henrik Oster; Gregor Eichele
Journal:  Elife       Date:  2019-07-11       Impact factor: 8.140
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.